Part 1: Close Up Radio Spotlights Dr. Patricia A. Broderick of Eazysense

New York, NY – Dr. Broderick is a Medical Professor in Molecular Cellular and Biomedical Sciences at The City University of New York School of Medicine. Associated with NYU Comprehensive Epilepsy Center and the Department of Neurology at NYU-Langone Medical Center, Dr. Broderick has contributed novel surgical interventions for neurodegenerative diseases intraoperatively.  Dr. Broderick is the Director of an innovative, creative Interdisciplinary Course, called Neurobiological Aspects of Drugs of Abuse for all undergrads at The City College of New York within the CUNY School of Medicine.     

Dr. Broderick is the first person to marry the brain with nanosensors to discover all new ways to treat the brain.

Dr. Broderick has invented, patented and trademarked a revolutionary technology that will change the way we understand the brain: The BRODERICK PROBE®, about which medical doctors have published, could change the face of science and medicine.

The founder of Eazysense Nanotechnologies Inc., Dr. Broderick has spent a career working on neurodegenerative diseases like epilepsy, Parkinson's and Alzheimer's, as well as biopsychiatric conditions like anxiety, depression, schizophrenia, schizoaffective disorders. Dr. Broderick is known worldwide as a unique pioneer in nanobiotechnology, leading the frontier in nanosensing biochemistry in the brain to alleviate the burden of these brain disorders. Patricia’s next book, a monograph, release date, June 30, 2020 is entitled Neuroimaging, Sensing Biochemistry in the Brain.

The work of Broderick and her team has led the way in Neuropsychopharmacology with direct extrapolation to what has and is happening globally to what she has coined: “The Covid Brain.”